MedInvest to Host Biotech and Pharma Investor Conference on March 31 & April 1, 2026 in New York City
MedInvest, a leading healthcare, biotech, and medtech media and conference company, will host its semi-annual Biotech and Pharma Investor Conference in New York City on March 31 and April 1, 2026. The National Institutes of Health, National Cancer Institute, and Pillsbury Law Firm will be presenting partners of the event.
The conference is expected to attract 100+ investors spanning venture and public funds, family offices, strategics, and government and non-profit grant making entities. The two-day event will consist of half a dozen talks by KOLs and investor panels.
During, before and after the conference for two weeks, meetings will be facilitated both in person and virtually via the conference’s partnering system.
Speakers at the last MedInvest Biotech and Pharma Investor Conference in September 2025 included :
Dr. Ira Mellman, President of Research, Parker Center for Cancer Immunotherapy | Former Vice President of Cancer Immunology, Genetech
Dr. Dean Felsher, Director of Translational Research and Applied Medicine, Stanford Medical School | Professor Medicine-Oncology and Pathology
Dr. Chris Apfel, Director of Life Sciences, Keiretsu Forum Bay Area | Founder and CEO, SageMedic
Dr. Phil DiGiacomo, Vice President, Venrock
Lior Teitelbaum, Principal, Venture Investments with J&J (JJDC)
Dr. Preetha Ram, Managing Partner, Pier 70 Ventures
Dr. Michel Azoulay, Chief Medical Officer, Institute for Follicular Lymphoma Innovation Institute for Follicular Lymphoma Innovation
Dr. Edny Inui, Partner, Palo Santo
Dr. Qing Zhang, Partner, LDV Partners
Dr. Chris Walters, Director of Investments and Business Development, Formation Bio
Dr. Abe Heifets, Founder, Atomwise
Dr. Hanadie Yousef, CEO, Juvena Therapeutics
Dr. Alfred Slanetz, Chairman of the National Foundation for Cancer Research and Former CEO iof Bluebird Bio
Steven Ferguson, Deputy Director, Licensing and Entrepreneurship, NIH
Dr. Michael Salgaller, Director of the Invention Development and Marketing Unit, NCI
Josh Seidenfeld, Partner, Cooley
Lauren Creel, Partner, Cooley
Lila Hope, Partner, Cooley